Patients with obstructive sleep apnea (OSA) who are administered oxygen therapy postoperatively may develop elevated levels of carbon dioxide (CO2), according to researchers.
The study, which used transcutaneous CO2 to measure CO2, found that 11.3% of study patients (14/123) had elevated CO2 in their blood, exceeding 55 mm Hg, “indicating a degree of respiratory depression in postoperative nights, mostly in the first post-op night,” said senior author Frances Chung, MBBS, FRCPC,